Peptidergic nerves in the colon of patients with ulcerative colitis

Hepato-Gastroenterology

Volumn 47, Issue 32, 2000, Pages 400-404

  Tomita, Ryouichi ^a   Tanjoh, Katsuhisa ^a   Fujisaki, Shigeru ^a   Fukuzawa, Masahiro ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Neurotensin; Non adrenergic non cholinergic enteric nervous system; Substance P; Ulcerative colitis; VIP

Indexed keywords

ATROPINE; NEUROTENSIN; PHENOXYBENZAMINE; PROPRANOLOL; SUBSTANCE P; TETRODOTOXIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; COLON; COLON MOTILITY; DIARRHEA; DRUG POTENCY; FEMALE; HUMAN; HUMAN TISSUE; INTESTINE CONTRACTION; INTESTINE INNERVATION; MALE; PATHOPHYSIOLOGY; PEPTIDERGIC NERVOUS SYSTEM; PRIORITY JOURNAL; TOXIC MEGACOLON; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; COLITIS, ULCERATIVE; COLON; ENTERIC NERVOUS SYSTEM; FEMALE; GASTROINTESTINAL MOTILITY; HUMANS; MALE; MIDDLE AGED; NEUROTENSIN; SUBSTANCE P; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0033994754     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. 1 Koch TR, Carney JA, Go VLW, Szurszewski JH: Spontaneous contractions and some electrophysiologic properties of circular muscle from normal sigmoid colon and ulcerative colitis. Gastroenterol 1988; 95:77-84.
2. 2 Snape WJ, Williams R, Hyman PE: Defect in colonic muscle contraction in patients with ulcerative colitis. Am J Physiol 1991; 261:G987-G991.
3. 3 Collin SM: The immune system. In: Kumar D, Wingate D (Eds.). An illustrated guide to gastrointestinal motility. Edinburgh, UK: Churchill Livingstone, 1993; pp. 120-129.
4. 4 Burnstock G, Campbell G, Bennett M, Holman ME: Inhibition of the smooth muscle of the taenia coli. Nature 1963; 200:581-582.
5. 5 Baumgarten HG, Holstein AF, Owman CH: Auerbach's plexus of mammals and man: Electron microscopic identification of three different types of neuronal processes in myenteric ganglia of the large intestine from rhesus monkeys, guinea-pig and man. Z Zellforsch 1970; 106:376-397.
6. 6 Furness JB, Costa M: The nervous release and the action of substances which affect intestinal muscle through neither adrenoreceptors nor cholinoreceptors. Philos Trans R Soc Lond 1973; B265:123-133.
7. 7 Furness JB, Costa M: Types of nerves in the enteric nervous system. Neurosience 1980; 5:1-20.
8. 8 Tomita R, Kurosu Y, Munakata K, Aoki N, Tanjoh K: Physiological studies on gastrointestinal hormones in the colon of patients with diverticular disease. Nihon Univ J Med 1993; 35:253-259.
9. 9 Tomita R, Munakata K, Kurosu Y: Peptidergic nerves in Hirschsprung's disease and its allied disorders. Eur J Pediatr Surg 1994; 4:346-351.
10. 10 Tomita R, Munakata K, Tanjoh K, Kurosu Y: Regulation of the enteric nervous system and innervation of peptidergic nerve in the colonic segment of elongated sigmoid colon. Biomed Res 1994; 15:195-201.
11. 11 Tomita R, Kurosu Y, Munakata K, Abe Y: Regulation of non-adrenergic non-cholinergic inhibitory nerves in the enteric nervous system of the lower esophageal sphincter in humans. Nihon Univ J Med 1995; 37:225-230.
12. 12 Tomita R, Munakata K, Tanjoh K: Regulation of non-adrenergic non-cholinergic inhibitory nerves in the colon of patients with ulcerative colitis. J Gastroenterol. (In press)
13. 13 Bishop AN, Polak JM, Bryant MG, Bloom SR, Hamilton S: Abnormalities of vasoactive polypeptide-containing nerves in Crohn's disease. Gastroenterol 1980; 79:853-860.
14. 14 Besterman HS, Mallinson CN, Modigliani R, Christofides ND, Pera A, Ponti V, Sarson DL, Bloom SR: Gut hormones in inflammatory bowel disease. Scand J Gastroenterol 1983; 18:845-852.
15. 15 O'Morain C, Bishop AN, McGregor GP, Levi AJ, Bloom SR, Polak JM, Peters TJ: Vasoactive intestinal peptide concentrations and immunocytochemical studies in rectal biopsies from patients with inflammatory bowel disease. Gut 1984; 25:57-61.
16. 16 Koch TR, Carney JA, Go VW: Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases. Dig Dis Sci 1987; 32:369-376.
17. 17 Goldin E, Karmeli F, Selinger Z, Rachmilewitz D: Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation. Dig Dis Sci 1989; 34:754-757.
18. 18 Grider JR: Identification of neurotransmitters regulating intestinal peristaltic reflex in human. Gastroenterol 1989; 97:1414-1419.
19. 19 Todorovice V, Janiv B, Koko V, Micev M, Nikolic JA, Ratkovic M, Leosavice G, Jankovic T, Knezevic-Usaj S, Milicevic Z: Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis - A radioimmunoassay and immunohistochemical study. Hepatogastroenterology 1993; 43:483-488.
20. 20 Berstein CN, Robert ME, Eysselein VE: Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn's disease. Am J Gastroenterol 1993; 88:908-913.
21. 21 Reubi JC, Mazzucchelli L, Laissue JA: Intestinal vessels express a high density of somatostatin receptors in human inflammatory bowel disease. Gastroenterol 1994; 106:951-959.
22. 22 Stark ME, Bauer AJ, Sarr MG: Nitric oxide mediates inhibitory nerve input in human and canine jejunum. Gastroenterol 1993; 104:398-409.
23. 23 Middleton SJ, Shorthouse M, Hunter JO: Increased nitric oxide synthesis in ulcerative colitis. Lancet 1993; 341:465-466.
24. 24 Boughton-Smith NK, Evans SM, Hawkey CJ, Cole AT, Balsitis M, Whittle BJR, Moncada S: Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet 1993; 342:338-340.
25. 25 Oudkerk PM, Bouma G, Visser JJ, Kolkman JJ, Tran DD: Serum nitrate levels in ulcerative colitis and Crohn' disease. Scand J Gastroenterol 1995; 30:784-788.
26. 26 Rachmilewitz D, Stamler J, Bachwich D, Karmeli F, Ackerman Z, Podolsky DK: Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 1995; 36:718-723.
27. 27 Neilly PJD, Kirk SJ, Gardiner KR, Anderson NH, Rowlands BJ: Manipulation of the L-arginine-nitric oxide pathway in experimental colitis. Br J Surg 1995; 82:1188-1191.
28. 28 Holtkamp W, Stollberg T, Reis HE: Serum Interleukin-6 is related to disease activity but not disease specificity in inflammatory bowel disease. J Clin Gastroenterol 1995; 20:123-126.